NCT03849599View on ClinicalTrials.gov

A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL

PRV-300

Treatment

BIOLOGICAL

Placebo

Control

Trial Locations (3)

Unknown

Clinical Site, Tbilisi

Clinical Site, Chisinau

Clinical Site, Kapitanivka

All Listed Sponsors

lead

Provention Bio, Inc.

INDUSTRY

NCT03849599 - A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter